Guidance

Diabetic eye screening: optical coherence tomography in surveillance

Guidance for diabetic eye screening providers on use of optical coherence tomography (OCT) in surveillance clinics.

From:
Public Health England
Published
8 July 2020
Last updated
10 July 2024 — See all updates

Documents

Optical coherence tomography (OCT) in diabetic eye screening (DES) surveillance clinics

Ref: PHE publications gateway number GW-1385

HTML

Optical coherence tomography (OCT) in diabetic eye screening (DES) surveillance clinics - Starting 1 October

HTML

OCT examples

Ref: PHE publications gateway number GW-1385

HTML

Diabetic eye screening: OCT in surveillance pathway

Ref: PHE publications gateway number GW-1385

HTML

Details

This document provides consistent best practice guidance for diabetic eye screening (DES) services on the management of diabetic maculopathy in digital surveillance (DS) clinics using optical coherence tomography (OCT).

Contact the PHE Screening helpdesk with any queries about this publication, making sure you include its full title.

Published 8 July 2020
Last updated 10 July 2024 + show all updates

  1. Updated guidance

  2. First published.